Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1Centrient Pharmaceuticals
02 1LGM Pharma
03 1Suanfarma
04 1DKSH
05 1Jai Radhe Sales
06 2Bajaj Healthcare
07 1CHEMO
08 1Chemo Biosynthesis
09 1Dalian Richon Chem
10 1Delta Synthetic Co. Ltd
11 1Diligent Life Care
12 1Hangzhou Think Chemical Co.Ltd
13 2Hebei Veyong Pharmaceutical
14 2Hengdian Group
15 2Hovione
16 1Industriale Chimica
17 1Merck & Co
18 1North China Pharmaceutical Co., Ltd.
19 1RICHBERYL BIOTECH CO., LTD. OF RAOYANG COUNTY
20 1SAMEX OVERSEAS
21 1Shandong Qilu King-Phar Pharmaceutical Co., Ltd
22 1Sinobright Pharmaceutical Company Ltd
23 1Tecoland Corporation
24 1Xian Tian Guangyuan Biotech
25 1Zhejiang Apeloa Kangyu Pharmaceutical Co. Ltd
26 1Zhejiang Hisun Pharmaceutical
27 3Blank
01 13China
02 5India
03 2Italy
04 1Netherlands
05 2Portugal
06 2Spain
07 1Switzerland
08 1Taiwan
09 3U.S.A
10 3Blank
01 4Active
02 3Inactive
03 26Blank
01 2Expired
02 7Valid
03 1Withdrawn by Holder
04 23Blank
01 1221MF10281
02 1304MF10006
03 1304MF10048
04 30Blank
01 33Blank
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-08
Pay. Date : 2012-12-18
DMF Number : 21624
Submission : 2008-05-08
Status : Active
Type : II
Certificate Number : R1-CEP 1999-176 - Rev 05
Issue Date : 2021-03-31
Type : Chemical
Substance Number : 1336
Status : Valid
Registration Number : 304MF10048
Registrant's Address : 46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province, P. R. China 318000
Initial Date of Registration : 2022-03-02
Latest Date of Registration : --
NDC Package Code : 58623-0047
Start Marketing Date : 2014-10-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5553
Submission : 1995-12-14
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-09
Pay. Date : 2012-12-14
DMF Number : 21395
Submission : 2008-03-05
Status : Active
Type : II
Certificate Number : R1-CEP 1998-138 - Rev 05
Issue Date : 2020-02-28
Type : Chemical
Substance Number : 1336
Status : Valid
Registration Number : 304MF10006
Registrant's Address : Estrada Coronel Nicolau de Mesquita Taipa, Macau S. A. R. China
Initial Date of Registration : 2022-01-11
Latest Date of Registration : --
NDC Package Code : 55018-121
Start Marketing Date : 1998-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-06
Pay. Date : 2022-01-13
DMF Number : 36494
Submission : 2021-11-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17673
Submission : 2004-07-18
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12755
Submission : 1997-11-21
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
We have 26 companies offering Ivermectin Merck Brand
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?